Preliminary experience with FK 506 in pancreas transplant recipients.
University of Nebraska Medical Center, Omaha 68198-3280, USA.
R J
RJ
Stratta
R J
RJ
Taylor
P
P
Castaldo
R
R
Sindhi
D
D
Sudan
K
K
Frisbie
K
K
Cushing
D001424:Bacterial Infections / Q000209:etiology; D003920:Diabetes Mellitus / Q000601:surgery; D006084:Graft Rejection / Q000188:drug therapy; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016035:Pancreas Transplantation / Q000009:adverse effects / Q000379:methods* / Q000502:physiology; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014777:Virus Diseases / Q000209:etiology
D007166:Immunosuppressive Agents; D016559:Tacrolimus